Selection of a Surrogate Agent (Fluconazole or Voriconazole) for Initial Susceptibility Testing of Posaconazole against Candida spp.: Results from a Global Antifungal Surveillance Program

There are currently no FDA-approved broth microdilution antifungal susceptibility testing products or interpretive breakpoints for susceptibility testing of the new triazole posaconazole. Fluconazole and voriconazole are in the same triazole class as posaconazole, have CLSI-approved interpretive MIC...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Pfaller, M. A., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J., Diekema, D. J.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology (ASM) 2008
Assuntos:
Mycology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2238086/
https://ncbi.nlm.nih.gov/pubmed/18094129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01952-07
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares